| Title : DPP-4 (CD26) inhibitor alogliptin inhibits TLR4-mediated ERK activation and ERK-dependent MMP-1 expression by U937 histiocytes - Ta_2010_Atherosclerosis_213_429 |
| Author(s) : Ta NN , Li Y , Schuyler CA , Lopes-Virella MF , Huang Y |
| Ref : Atherosclerosis , 213 :429 , 2010 |
| Abstract : |
| PubMedSearch : Ta_2010_Atherosclerosis_213_429 |
| PubMedID: 20843518 |
| Title : DPP-4 (CD26) inhibitor alogliptin inhibits TLR4-mediated ERK activation and ERK-dependent MMP-1 expression by U937 histiocytes - Ta_2010_Atherosclerosis_213_429 |
| Author(s) : Ta NN , Li Y , Schuyler CA , Lopes-Virella MF , Huang Y |
| Ref : Atherosclerosis , 213 :429 , 2010 |
| Abstract : |
| PubMedSearch : Ta_2010_Atherosclerosis_213_429 |
| PubMedID: 20843518 |
| Title : DPP-4 (CD26) inhibitor alogliptin inhibits TLR4-mediated ERK activation and ERK-dependent MMP-1 expression by U937 histiocytes - Ta_2010_Atherosclerosis_213_429 |
| Author(s) : Ta NN , Li Y , Schuyler CA , Lopes-Virella MF , Huang Y |
| Ref : Atherosclerosis , 213 :429 , 2010 |
| Abstract : |
| PubMedSearch : Ta_2010_Atherosclerosis_213_429 |
| PubMedID: 20843518 |